Puremedy Blog

Big Pharma Ditches Antibiotic Research When It’s Needed Most - Puremedy Responds

"Every year, at least 2 million Americans get infected with bacteria that have evolved to resist antibiotics, and at least 23,000 people die. Globally, resistant pathogens take 700,000 lives annually. Given this level of disease and death, you might think Big Pharma would be scrambling to come up with new antibiotics to cash in on the rising tide of resistance." (Mother Jones, 2018). 

The WHO recently said that the superbug crisis is one of the three threats to human existence next to WW III and climate change.

Here’s the thing. Big Pharma knows that stronger antibiotics will breed stronger bacteria. But Einstein famously said, a problem cannot really be solved at the level of consciousness that created the problem. And so it goes with antibiotics.

My company is built on a topical healing ointment that was invented over 150 years ago by an Indigenous Medicine man, utilizing tree resins, barks and extracts. I’ve attached a time-kill analysis. It kills all tested bacteria (gram positive and gram negative) fast, about 90% or more in the first one minute.

The method of action is different than an antibiotic, which tricks bacteria into not reproducing. But our topical ointment simply traps the bacteria in a water free air free environment and suffocates the organisms. This is exactly why many many leading researchers and doctors have advocated looking to nature for answers.

I have also been working with the FDA regarding regulatory issues. Unfortunately, you’re right, it’s all about profits. In order to file an application for my product to be evaluated but the FDA as a drug, the application fee alone is… $2.5 million.

I would think that the FDA would be not only helpful but anxious to help get the right products to people. But that’s not the mission of the FDA. FDA Mission. The Food and Drug Administration is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation's food supply, cosmetics, and products that emit radiation.

A good friend of mine is recently said, “If there were a cure for cancer out there the FDA would make sure we all could get it.” But that’s absolutely not the case. The FDA is not in the business of curing disease. They are in the business of enforcing strict compliance in an industry where only large wealthy companies are allowed access.

Innovation in the area of superbug control will ONLY happen with smaller companies who are willing to invest their own resources in testing and proving efficacy. Another key component is public education. So thank you again for writing about this.

Nature has been keeping microbes in balance for billions of years. We truly need to look to nature to manage this problem. I believe that Puremedy has the answer to the superbug epidemic in the Original Healing Salve. The sophisticated blend of pine, fir and elder tree extracts is proving to kill the toughest, most recent superbugs out there.

Lastly, the numbers you reported are probably very low. Within the past 10 years, hospitals have changed the way they report deaths due to MRSA and other superbugs. They used to ask for the specific microbe to new noted on the death certificate. Now, they lump all infections under a broad category. The result is, we are dramatically underreporting the numbers of deaths each year actually caused by superbugs. Insiders tell me that the medical world is “freaking out” because they only see the problem worsening, not improving.


Response to Article:

https://www.motherjones.com/food/2018/07/big-pharma-ditches-antibiotic-research-when-its-needed-most/

 

Follow Us
Subscribe to RSS Feed